The role of thiopurine metabolite monitoring in inflammatory bowel disease

Lauren Beswick, Antony B. Friedman, Miles P. Sparrow

Research output: Contribution to journalReview ArticleOtherpeer-review

9 Citations (Scopus)

Abstract

Thiopurines are the mainstay of medical management in inflammatory bowel disease (IBD), especially in the maintenance of disease remission. Given the limited IBD armamentarium it is important to optimize each therapy before switching to an alternative drug. Conventional weight based dosing of thiopurines in IBD leads to intolerance or inefficacy in many patients. More recently increased knowledge of their metabolism has allowed for dose optimization using thiopurine metabolite levels, namely 6-thioguanine nucleotides and 6-methylmercaptopurine, with the potential for improved outcomes in patients with IBD. This review will outline the current understanding of thiopurine metabolism and pharmacogenomics and will describe the clinical application of this knowledge in the optimization of thiopurines in individual patients.

Original languageEnglish
Pages (from-to)383-392
Number of pages10
JournalExpert Review of Gastroenterology and Hepatology
Volume8
Issue number4
DOIs
Publication statusPublished - 2014

Keywords

  • 6-mercaptopurine
  • allopurinol
  • azathioprine
  • inflammatory bowel disease
  • metabolism
  • thiopurine methyl transferase
  • thiopurines

Cite this

@article{d7e72e8ff66d413bbac52e64051c47a8,
title = "The role of thiopurine metabolite monitoring in inflammatory bowel disease",
abstract = "Thiopurines are the mainstay of medical management in inflammatory bowel disease (IBD), especially in the maintenance of disease remission. Given the limited IBD armamentarium it is important to optimize each therapy before switching to an alternative drug. Conventional weight based dosing of thiopurines in IBD leads to intolerance or inefficacy in many patients. More recently increased knowledge of their metabolism has allowed for dose optimization using thiopurine metabolite levels, namely 6-thioguanine nucleotides and 6-methylmercaptopurine, with the potential for improved outcomes in patients with IBD. This review will outline the current understanding of thiopurine metabolism and pharmacogenomics and will describe the clinical application of this knowledge in the optimization of thiopurines in individual patients.",
keywords = "6-mercaptopurine, allopurinol, azathioprine, inflammatory bowel disease, metabolism, thiopurine methyl transferase, thiopurines",
author = "Lauren Beswick and Friedman, {Antony B.} and Sparrow, {Miles P.}",
year = "2014",
doi = "10.1586/17474124.2014.894878",
language = "English",
volume = "8",
pages = "383--392",
journal = "Expert Review of Gastroenterology & Hepatology",
issn = "1747-4124",
publisher = "Taylor & Francis",
number = "4",

}

The role of thiopurine metabolite monitoring in inflammatory bowel disease. / Beswick, Lauren; Friedman, Antony B.; Sparrow, Miles P.

In: Expert Review of Gastroenterology and Hepatology, Vol. 8, No. 4, 2014, p. 383-392.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - The role of thiopurine metabolite monitoring in inflammatory bowel disease

AU - Beswick, Lauren

AU - Friedman, Antony B.

AU - Sparrow, Miles P.

PY - 2014

Y1 - 2014

N2 - Thiopurines are the mainstay of medical management in inflammatory bowel disease (IBD), especially in the maintenance of disease remission. Given the limited IBD armamentarium it is important to optimize each therapy before switching to an alternative drug. Conventional weight based dosing of thiopurines in IBD leads to intolerance or inefficacy in many patients. More recently increased knowledge of their metabolism has allowed for dose optimization using thiopurine metabolite levels, namely 6-thioguanine nucleotides and 6-methylmercaptopurine, with the potential for improved outcomes in patients with IBD. This review will outline the current understanding of thiopurine metabolism and pharmacogenomics and will describe the clinical application of this knowledge in the optimization of thiopurines in individual patients.

AB - Thiopurines are the mainstay of medical management in inflammatory bowel disease (IBD), especially in the maintenance of disease remission. Given the limited IBD armamentarium it is important to optimize each therapy before switching to an alternative drug. Conventional weight based dosing of thiopurines in IBD leads to intolerance or inefficacy in many patients. More recently increased knowledge of their metabolism has allowed for dose optimization using thiopurine metabolite levels, namely 6-thioguanine nucleotides and 6-methylmercaptopurine, with the potential for improved outcomes in patients with IBD. This review will outline the current understanding of thiopurine metabolism and pharmacogenomics and will describe the clinical application of this knowledge in the optimization of thiopurines in individual patients.

KW - 6-mercaptopurine

KW - allopurinol

KW - azathioprine

KW - inflammatory bowel disease

KW - metabolism

KW - thiopurine methyl transferase

KW - thiopurines

UR - http://www.scopus.com/inward/record.url?scp=84898936829&partnerID=8YFLogxK

U2 - 10.1586/17474124.2014.894878

DO - 10.1586/17474124.2014.894878

M3 - Review Article

VL - 8

SP - 383

EP - 392

JO - Expert Review of Gastroenterology & Hepatology

JF - Expert Review of Gastroenterology & Hepatology

SN - 1747-4124

IS - 4

ER -